Although the pathogenesis of chronic hepatitis C is poorly understood, recent studies implicate the dynamic interactions which occur between HCV and the infected host as key determinants of viral persistence and disease progression. Studies in humans indicate that genetic evolution of HCV to form viral quasispecies, and the strength of host CD4 and CDS response against HCV antigens are both critically linked to persistence of infection and progression of chronic liver disease. However, research confirming a direct interplay between HCV evolution and the immune responses of individual patients with specific outcomes needs to be performed. The overall goal of this proposal is to gain a better understanding of the pathogenesis of hepatitis C by investigating the relationships between HCV genetic evolution and host immune responses as they relate to resolution or persistence of infection and progression or non- progression of chronic liver disease. We will study subjects from the Alaska Native and American Indian cohort, taking advantage of a serum bank which dates back over 30 years and a large clinical and virological database compiled on approximately 1000 subjects over the past 8 years. HCV genetic evolution will be studied in the context of host immune responses in different clinical settings. Results from these studies will further our understanding of the mechanisms of HCV persistence and liver disease progression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI066209-04
Application #
7600651
Study Section
Special Emphasis Panel (ZRG1-CRFS-C (01))
Program Officer
Koshy, Rajen
Project Start
2006-04-01
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
4
Fiscal Year
2009
Total Cost
$417,803
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bruden, Dana J T; McMahon, Brian J; Townshend-Bulson, Lisa et al. (2017) Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort. Hepatology 66:37-45
Atkins, Elizabeth; Tatineni, Ranjitha; Li, Hui et al. (2014) The stability of secreted, acid-labile H77/JFH-1 hepatitis C virus (HCV) particles is altered by patient isolate genotype 1a p7 sequences. Virology 448:117-24
Li, Hui; Sullivan, Daniel G; Feuerborn, Nathan et al. (2010) Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation. Virology 402:248-55
McMahan, Rachel H; Golden-Mason, Lucy; Nishimura, Michael I et al. (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120:4546-57
McMahon, Brian J; Bruden, Dana; Bruce, Michael G et al. (2010) Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection. Gastroenterology 138:922-31.e1
Golden-Mason, Lucy; Palmer, Brent E; Kassam, Nasim et al. (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 83:9122-30
Li, Hui; McMahon, Brian J; McArdle, Susan et al. (2008) Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. Virology 375:580-91
Li, Hui; Thomassen, Lisa V; Majid, Ayaz et al. (2008) Investigation of putative multisubtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes. J Virol 82:7524-32
Scott, John D; Gretch, David R (2007) Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA 297:724-32